ASX Blue-Chips: High-Yield Dividend Picks

The Australian share market, particularly its blue-chip segment, presents a fertile ground for investors seeking robust dividend yields. Larger, established companies on the ASX often trade at more modest valuations, reflected in lower price-to-earnings (P/E) ratios. This pricing dynamic, combined with a reduced need to retain substantial cash reserves for aggressive expansion compared to smaller, high-growth entities, typically allows these larger firms to distribute a more generous portion of their profits as dividends, thereby boosting dividend yields.

Let’s explore two prominent ASX-listed companies that stand out for offering significantly higher dividend yields than the broader market.

Medibank Private Ltd (ASX: MPL): A Defensive Powerhouse in Private Health Insurance

Medibank Private Ltd, operating under the well-recognised Medibank and ahm brands, is Australia’s largest private health insurer. Beyond its core insurance offerings, the company is strategically expanding its Medibank Health division. This expansion includes primary care services through recent acquisitions and a growing presence in community-based and acute home health services.

The healthcare sector is inherently defensive, meaning it tends to be less susceptible to economic downturns. This resilience translates into more stable and predictable earnings for companies like Medibank, which in turn supports the consistent payment of dividends. In a recent update, Medibank highlighted its ability to demonstrate growth across various economic cycles, deliver value to both customers and shareholders, and successfully navigate prevailing market challenges.

Furthermore, industry data from APRA’s quarterly private health insurance statistics indicated a 2.1% industry growth in the 12 months leading up to December 31, 2025. This growth is partly attributed to increased participation from younger demographics, a trend that bolsters both the affordability and the long-term sustainability of the private health insurance sector. Medibank is also poised to benefit from Australia’s ongoing demographic shifts, including an ageing population and overall population growth, which are likely to drive demand for its services.

Medibank has a commendable history of rewarding its shareholders with regular dividend increases. Between the financial years FY15 and the FY26 half-year results, the company managed to increase its annual dividend payout every year, with the exception of FY20, which was impacted by the unforeseen circumstances of the COVID-19 pandemic. This consistent track record underscores its commitment to dividend growth.

Projections from CMC Invest suggest that Medibank is anticipated to pay an annual dividend per share of 19 cents for FY26. When factoring in franking credits, this translates to a grossed-up dividend yield of approximately 5.6% as of the time of writing.

WAM Leaders Ltd (ASX: WLE): Strategic Investment in Top-Tier ASX Businesses

WAM Leaders Ltd (ASX: WLE) is a listed investment company (LIC) managed by the reputable Wilson Asset Management (WAM). The company’s investment strategy is focused on identifying and investing in the most attractive, larger-cap businesses listed on the Australian Securities Exchange (ASX).

By concentrating its portfolio on ASX blue-chip shares, WAM Leaders aims to construct a portfolio that exhibits greater resilience compared to portfolios focused solely on high-growth stocks. This approach seeks to provide investors with a more stable investment vehicle, particularly in volatile market conditions.

The top holdings within the WAM Leaders portfolio typically include a strong representation of Australia’s leading companies. While specific holdings can fluctuate, some of the largest 20 positions have historically featured:

• ANZ Group Holdings Ltd (ASX: ANZ)
• BHP Group Ltd (ASX: BHP)
• Commonwealth Bank of Australia (ASX: CBA)
• Goodman Group (ASX: GMG)
• Macquarie Group Ltd (ASX: MQG)
• National Australia Bank Ltd (ASX: NAB)
• REA Group Ltd (ASX: REA)
• Rio Tinto Ltd (ASX: RIO)
• Westpac Banking Corp (ASX: WBC)
• Woodside Energy Group Ltd (ASX: WDS)
• Wesfarmers Ltd (ASX: WES)

This composition clearly demonstrates the LIC’s significant emphasis on established blue-chip companies.

Since its inception in May 2016, WAM Leaders’ portfolio has demonstrated a history of outperformance relative to the S&P/ASX 200 Accumulation Index (ASX: XJOA). The LIC has achieved a gross annual return of 11.9% (before fees, expenses, and taxes), surpassing the index’s return of 9% per year. It is important to note, however, that past performance is not a reliable indicator of future results.

WAM Leaders has also been dedicated to increasing its annual dividend payouts. Between FY17 and FY25, the company successfully grew its annual dividend each year. For FY26, it anticipates a further increase in its annual payout to 9.6 cents per share, representing a 2.1% rise. This projected dividend, when grossed-up to include franking credits, offers a potential dividend yield of approximately 10.4% as of the time of writing.